Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is there a future for liver-assist devices?

P Rosenthal1

  • 1Pediatric Liver Transplant Program, Department of Pediatric Hepatology, University of California, San Francisco, 500 Parnassus Avenue, Box 0136, MU 4-East, San Francisco, CA 94143-0136, USA. prosenth@peds.ucsf.edu.

Current Gastroenterology Reports
|September 12, 2000
PubMed
Summary

Fulminant hepatic failure patients may recover with liver support systems that bridge them to transplantation or allow native liver regeneration. Early bioartificial liver support results are promising but require further randomized trials for efficacy confirmation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: an expert consensus for the management of chronic hepatitis B in Asian Americans.

Alimentary pharmacology & therapeutics·2018
Same author

Quality of life in adolescents with hepatitis C treated with sofosbuvir and ribavirin.

Journal of viral hepatitis·2017
Same author

Metabolic Syndrome Components After Pediatric Liver Transplantation: Prevalence and the Impact of Obesity and Immunosuppression.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Under Utilization of Pancreas Transplants in Cystic Fibrosis Recipients in the United Network Organ Sharing (UNOS) Data 1987-2014.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Posttransplant metabolic syndrome in the withdrawal of immunosuppression in Pediatric Liver Transplant Recipients (WISP-R) pilot trial.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Decreased risk of graft failure with maternal liver transplantation in patients with biliary atresia.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012

Area of Science:

  • Hepatology
  • Regenerative Medicine
  • Transplantation Medicine

Background:

  • Fulminant hepatic failure (FHF) presents two patient profiles: those requiring liver replacement and those with potentially reversible injury.
  • Liver support systems aim to stabilize patients hemodynamically, bridging them to liver transplantation or enabling native liver recovery.

Purpose of the Study:

  • To evaluate the role and efficacy of liver support systems in managing fulminant hepatic failure.
  • To assess the potential of bioartificial liver support in facilitating liver regeneration or bridging to transplantation.

Main Methods:

  • Review of current approaches to liver support in FHF.
  • Analysis of preliminary data from bioartificial liver support systems.

Related Experiment Videos

Main Results:

  • Limited successes with bioartificial liver support in FHF patients are noted.
  • Current data lacks randomization, control groups, and stratification by disease severity or etiology.

Conclusions:

  • Bioartificial liver support shows early promise for FHF management.
  • Randomized, controlled trials are crucial to determine the definitive efficacy of these systems in diverse FHF patient populations.